MISSION: PXE International initiates, funds and conducts research; provides support for individuals and families affected by pseudoxanthoma elasticum; and provides resources for healthcare professionals.
Track the progress of your Annual Appeal donations. ANNUAL APPEAL
Rescheduled: General Overview of PXE Webinar
The General Overview of PXE webinar scheduled for Thursday, 12/18/08, has been rescheduled. Although interest was high, we realized we needed to make it a two-part presentation to allow adequate time for questions. We apologize for any inconvenience this may have caused.
General Overview of PXE: Part 1 Register General Overview of PXE: Part 2 Register
Join us in January for our next webinar, PXE Research, with Patrick Terry, President, PXE International. Register for PXE Research
Avastin News - Genentech agrees to allow ophthalmologists access to Avastin for intraocular injection in the treatment of potentially blinding diseases [12-20-2007]
Experts present on specific topics related to PXE via computer and teleconference call.
January 14 - PXE Research March 26 - General Overview, Pt 1 April 16 - General Overview, Pt 2 May TBD - PXE and the Eye
Find out how it all works - FAQ Dates and times - Registration
What is PXE?
Pseudoxanthoma elasticum (PXE) is an inherited disorder that causes select elastic tissue in the body to become mineralized. Learn more about PXE signs, effects and medical care in the PXE General Bulletin.
Website best viewed with Internet Explorer 5.5+. Other browsers may have formatting issues.
